PUBLICATIONS

1. Pincus SH and Kelbanoff SJ: Quantitative leukocyte iodination. New Eng J Med 284:744-750, 1971.


2. Klebanoff SJ and Pincus SH: Hydrogen peroxide utilization in myeloperoxidase deficient leukocytes: A possible control mechanism. J Clin Invest 50:2226-2229, 1971.


3. Giblett ER, Klebanoff SJ, Pincus SH, Swanson J, Park BH, and McCullough J: Kell phenotypes in chronic granulomatous disease: A potential transfusion hazard. Lancet 1:1235, 1971.


4. Pincus SH, Thomas IT, Clark RA, and Ochs HD: Defective neutrophil chemotaxis with variant ichthyosis hyperimmunoglobulinemia E and recurrent infections. J Ped 87:908-911, 1975.


5. Pincus, SH, Boxer LA, and Stossel TP: Chronic neutropenia in childhood: Analysis of 16 cases and a review of the literature. Am J Med 61:849-861, 1976.


6. Pincus SH: Production of eosinophil-rich guinea pig peritoneal exudates. Blood 52:127-134, 1978.


7. Pincus SH: Comparative metabolism of guinea pig eosinophils and neutrophils. Proc Soc Exp Biol Med 163: 482-489, 1980.


8. Pincus SH: Peroxidase mediated iodination by guinea pig peritoneal exudate eosinophils. Inflamm 4:89-106, 1980.


9. Wolf R, Pincus SH, Rosen F, and Merler E: Diffuse cutaneous lymphoma secreting a potent immunosuppressant. Clin Immunol Immunopathol 18:351-361, 1981.


10. Pincus SH, Butterworth A, David JR, Robbins M, and Vadas M: Antibody-dependent eosinophil mediated damage to schistosomula of Schistosoma mansoni: Lack of requirement for oxidative metabolism. J Immunol 126: 1794-1798, 1981.


11. Pincus SH, DiNapoli AM, Schooley WR, and Broder S: Metabolic heterogeneity among eosinophils from normal and hypereosinophilic patients. Blood 58: 1175-1181, 1981.


12. Kelly RA, Gelfand JA, and Pincus SH: Cutaneous necrosis caused by systemically administered heparin. JAMA 246: 1502-1503, 1981.


13. Pincus SH, DiNapoli AM, and Schooley WR: Superoxide production by eosinophils. Modulation by histamine. J Invest Dermatol 79: 53-57, 1982.


14. Pincus SH: Hydrogen peroxide release from eosinophils: Quantitative comparative studies of human and guinea pig eosinophils. J Invest Dermatol 80: 278-281, 1983.


15. Vadas MA, Varigos G, Nicola N, Pincus SH, Dessein A, Metcalf D, and Battye FL: Eosinophil activation by colony stimulating factor in man: Analysis by flow cytometry. Blood 61: 1232-1242, 1983.


16. Pincus SH, Dessein A, Lenzi H. and David JR: Eosinophil-mediated killing of schistosomula of Schistosoma mansoni: Oxidative requirement for enhancement by eosinophil colony stimulating factor (CSF-alpha) and supernatants with cytotoxicity enhancing activity (E-CEA). Cell Immunol 87: 424-433, 1984.


17. Jacoby W, Cammarata PC, Findlay S, and Pincus SH: Anaphylaxis in mast cell deficient mice. J Invest Dermatol 83: 302-304, 1984.


18. Pincus, SH: Eosinophil-particle interactions. A model system for study of cellular adherence and activation. Cell Immunol 86: 460-471, 1984.


19. Bjornson BB, Pincus SH, DiNapoli AM, and Desforges JA: Inhibition of CFU-NM and CFU-EOS by mature granulocytes. Blood 63: 376-379, 1984.


20. Pincus SH, and Cammarata PC: Eosinophil adherence to muscle larvae of Trichinella spiralis: Quantification and modulation. Immunology 56: 219-225, 1985.


21. Ramesh KS , Pincus SH, and Rocklin R: Human lymphocyte-eosinophil interactions. I. Modulation of phytohemagglutinin-induced lymphocyte proliferation by eosinophils. Cell Immunol 92: 366-375, 1985.


22. Pincus SH: Lectin binding by eosinophils. Proc Soc Exp Bio Med 182: 344-349, 1986.


23. Pincus SH, Cammarata PC, Delima M, and Despommier D: Eosinophilia in murine trichinellosis. J Parasitol 72: 321-325, 1986.


24. Pincus SH, Whitcomb E, and Dinarello CA: Interaction of IL-l and TPA in modulation of eosinophil function. J Immunol 137: 3509-3514, 1986.


25. Ramesh KS , Rocklin R, and Pincus SH: Activated eosinophils synthesize new proteins. Biochem Biophys Acta 923: 241-249, 1987.


26. Kaplan MM, Arora S, and Pincus SH: Primary sclerosing cholangitis. Clinical and histological response to low-dose methotrexate therapy. Ann Intern Med 106: 231235, 1987.


27. Pincus SH, Ramesh KS, and Wyler DJ: Eosinophils stimulate fibroblast DNA synthesis. Blood 70: 572-574, 1987.


28. Ramesh KS , Rocklin R, and Pincus SH: Phosphorylation and dephosphorylation of soluble proteins in human eosinophils. J Cell Biochem 34: 203-211, 1987.


29. Holick MF, Smith E, and Pincus SH: Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Arch Dermatol 123: 1677-1683a, 1987.


30. Smith EL, Pincus SH, Donovan L, and Holick MF: A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Amer Acad Dermatol 19: 516-528, 1988.


31. Baskar P, and Pincus SH: Eosinophil degranulation: Enhancement in the presence of oxygen. Infect Immun 56: 1907-1911, 1988.


32. Konnikov N, Dinarello CA, and Pincus SH: Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Derm 92: 235-239, 1989.


33. Whitcomb EA, Dinarello CA, and Pincus SH: Effects of IL-1 alpha and IL-1 beta on different subpopulations of human peripheral blood eosinophils. Blood 73: 1904-1908, 1989.


34. Whitcomb EA, Dinarello CA, and Pincus SH: Modulation of eosinophil function by tumor necrosis factor. Int Arch Allergy Appl Immunol 89: 250-255, 1989.


35. Romero L, Ikejima T, and Pincus SH: In situ localization of interleukin 1 in normal and psoriatic skin. J Invest Derm 93: 518-522, 1989.


36. Baskar P, Silberstein D, and Pincus SH: Inhibition of IgG triggered eosinophil function by IL-4. J of Immun. 144: 2321-2326, 1990.


37. Baskar P, and Pincus SH: Eosinophil degranulation: Selective regulation of enzyme release by IL-1 beta. Proc. Soc Exp Bio and Med 199 (2): 249-54, 1992.


38. Kircik LH, Wirth P, Pincus SH: Scars on the legs: Cutaneous fibrosis resulting from intracutaneous injection of cocaine. Arch Dermat 128 (12): 6143-0, 1992.


39. Romero L, Pincus SH: Interleukin 6 in normal skin and atrophic cutaneous disease. Inter Arch Allergy Immun. 99 (1): 44-49, 1992.


40. Conway B, Baskar P, Bechtel LJ, Kaplan JC, Hirsch MS, Schooley RT, Pincus SH: Eosinophils as host cells for HIV-1, Arch Virol 127 (1-4): 373-377, 1992.


41. Wieselthier J, Pincus S: Hailey-Hailey disease of the vulva: A report of 3 cases and review of the literature. Arch Derm 129(10): 1344-1345, 1993.


42. Amster M. Conway J, Zeid M. Pincus S: Cutaneous necrosis secondary to protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Derm. 29 (5) part 2, Suppl.: 853-857, 1993.


43. Zellis S, Pincus SH: When the pregnant woman experiences itching. Dermatology Nursing 5:380-383, 1993.


44. Birkland T. Cheavens M. Pincus S: Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Derm Res: 286: 312-318, 1994.


45. Pincus S: Women in Academic Dermatology: Results of survey from the professors of dermatology. Arch Derm 130: 1131-1135, 1994.


46. Kircik L, Armus S, Kipping H, and Pincus SH: Eccrine poroma in an unusual location. Cutis 54: 183-184, 1994.


47. Foon K, Vaickus L, Oseroff AR, Russell RN, Bernstein Z, Pincus S. et al: Immune responses in patients with cutaneous T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Clin Can Res 1: 1285-1294, 1995.


48. Zellis S, Pincus S: Treatment of vulvar dermatoses. Seminars in Derm 15(1): 71-76, 1996.


49. Guzzo C, Lazarus G, Goffe B, Pincus S. et al: Topical calcipotriene has short term no effect on calcium and bone metabolism of patients with psoriasis. J of Amer Acad Dermatol 34: 429-433, 1996.


50. Mashek H, Licznerski B, Pincus S: Tungiasis in New York. International J of Derm 36: 276-301, 1997.


51. Spellman MC, Pincus SH: Efficacy and safety of azelaic acid and glycolic acid combination therapy compared to tretinoin therapy for acne. Clin Therapeutics 20 (4), 7ll-721, 1998.


52. Lowe NJ , Rizk D, Grimes P, Billips M, and Pincus S: Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Therapeutics 20 (5): 945-959, 1998.


53. Christiano AM, Crollick J, Pincus S, and Uitto J: Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic. Exp Dermatology 8 (2): 146-152, 1999.


54. Pincus S, Wolff E, and Melander E. The VA National Quality Scholars Fellowship Program: Current Status, Future Directions. Quality Management in Health Care10 (3): 71-76, 2002.


55. Keitz S, Holland G, Melander E, Bosworth H, and Pincus S for the Learners’ Perceptions Working Group. The Veterans Affairs Learners’ Perceptions Survey: The Foundation for Educational Quality Improvement. Academic Medicine 78 (9): 910-917, 2003.


56. Singh D, Holland G, Melander E, Mickey D, and Pincus S. VA's Role in U.S. Health Professions Workforce Planning. Papers and Proceedings of the 13 th Federal Forecasters Conference of 2003 127-133, 2004.


57. Chang BK, Murawsky J, Feldman J, Holland G, Kashner T, Pincus S, and Sanders K. Resident Physicians in VA Outpatient Clinics: Continuity and Advanced Clinic Access Implementation. Fed Pract 24(5):35-54, 2007.